In an effort to provide greater transparency into the financial relationships between healthcare practitioners (HCPs) and healthcare organizations (HCOs) and medical product manufacturers, various cities, counties, and states (also known as “jurisdictions”) have enacted legislation that requires the disclosure of data related to these relationships. Depending on the jurisdiction’s requirements, Life Sciences companies must report certain interactions, payments, transfers of value, and/or product samples provided to HCPs and HCOs. These jurisdictions also have different reporting deadlines:
Pharmaceutical manufacturers report on payments made to HCPs and HCOs for travel, research, gifts, speaking engagements, meals, entertainment, education, and other purposes. Additionally, some jurisdictions require reporting on product samples, vouchers, and coupons provided to HCPs. In some instances, pharmaceutical manufacturers must register with the jurisdiction or inform them that a report will be submitted, collect data for the specified reporting period related to these expenditures, format the data according to jurisdictional requirements, and submit the report by that jurisdiction’s deadline.
To reduce the complexity of complying with these regulations, MedPro Systems® and Porzio Life Sciences partnered to create Porzio AggregateSpendID® (PASID), the leading end-to-end Aggregate Spend solution. PASID enables customers to identify, collect, and review HCP and HCO general spend, research, and samples transactions and integrate expenditures from multiple sources. The disparate data is collected into a central data repository and matched in real-time against the over 21M-record HCP/HCO MedProID® database for accuracy. Customers can then generate reports that satisfy the requirements of the Sunshine Act / Open Payments Program, the Food and Drug Administration’s samples reporting regulations, and State and Local Aggregate Spend regulations.